Background: Garbhashaya–yoni Bhransh*, described in Ayurveda under various Yonivyapadas, closely correlates with utero-vaginal prolapse in modern gynecology. It is commonly observed in multiparous and postmenopausal women and significantly affects quality of life. Surgical management is often associated with recurrence, morbidity, and limited acceptability, highlighting the need for effective conservative therapies. Objective: To evaluate and compare the clinical efficacy of oral Ashwagandha Churna with local Madanphaladi Pottali* versus Madanphaladi Pottali alone in the management of Garbhashaya–yoni Bhransh. Materials and Methods: A randomized, open-label, comparative clinical trial was conducted on 40 patients diagnosed with Garbhashaya–yoni Bhransh. Patients were randomly divided into two groups. Group A received Ashwagandha Churna orally along with local Madanphaladi Pottali, while Group B received Madanphaladi Pottali alone for three months, followed by one month of drug-free follow-up. Assessment was done using predefined subjective and objective parameters. Results: Both groups showed statistically significant improvement in subjective and objective parameters. Group B showed higher improvement in several subjective symptoms, whereas Group A demonstrated comparatively better improvement in certain objective parameters. Inter-group comparison revealed no statistically significant difference (χ² = 0.48, p = 0.789). Conclusion: Both treatment modalities were found to be safe, effective, and comparable. Ashwagandha Churna with Madanphaladi Pottali and Madanphaladi Pottali alone can be considered effective conservative Ayurvedic treatments for Garbhashaya–yoni Bhransh.
Diksha Jain*1, Jaya Srivastava2, Shashi Sharma3 (Sun,) studied this question.